US insurer Unum has delivered a quarterly report marked by both achievements and setbacks, revealing underlying strategic shifts that could fundamentally reshape the company’s future. While certain financial metrics fell short of projections, management signaled a decisive move toward risk reduction through a multi-billion dollar transaction in its volatile long-term care segment.
Shareholder Returns and Institutional Confidence Remain Strong
Despite operational headwinds, Unum continues to demonstrate its commitment to shareholder value through consistent capital returns. The company announced its 16th consecutive dividend increase, raising the quarterly payout by 9.5% to $0.46 per share. This adjustment extends Unum’s impressive track record of uninterrupted dividend distributions to 39 years, highlighting management’s focus on sustainable cash generation and investor rewards.
Institutional investors appear to endorse this approach. Recent regulatory filings show Adage Capital Partners expanded its position by 65.2% during the first quarter of 2025. Other significant institutions including Vident Advisory and Caisse DE Depot ET Placement DU Quebec also substantially increased their holdings, reflecting professional confidence in Unum’s strategic direction.
Q2 2025 Earnings: A Mixed Financial Picture
When Unum released its second-quarter 2025 results on July 29, the figures presented a complex narrative. Adjusted earnings per share reached $2.07, notably missing analyst consensus estimates ranging between $2.22 and $2.23. Conversely, revenue performance exceeded expectations with $3.36 billion against projections of $3.33 billion.
Segment performance varied considerably. While Unum US reported premium income growth of 3.9%, its adjusted operating income declined by 11.0%. The Closed Block segment experienced particularly significant pressure, with earnings plummeting from $51.6 million to just $3.9 million. This contraction primarily resulted from lower policyholder mortality rates coupled with higher average claim amounts.
Should investors sell immediately? Or is it worth buying Unum?
Strategic Reinsurance Transaction Reshapes Risk Exposure
The quarter’s most consequential development was Unum’s landmark reinsurance agreement with Fortitude Re. Through this transaction, Unum transferred $3.4 billion in long-term care reserves alongside approximately $120 million in ongoing disability insurance premiums. This strategic maneuver substantially reduces the company’s exposure to its historical long-term care business and is expected to generate approximately $100 million in capital benefits.
Notably, Unum will retain servicing responsibilities for the affected policies, ensuring continuity for customers while the company optimizes its capital structure and risk profile.
Solid Financial Foundation Despite Market Challenges
Unum maintains robust fundamental metrics that provide stability amid ongoing operational adjustments. The company holds $2.0 billion in holding company liquidity and maintains a risk-based capital ratio of approximately 485%—significantly exceeding regulatory targets. With a current market valuation of around $12.4 billion, the insurer continues navigating complex market conditions through disciplined governance and strategic risk management.
The central question remains whether Unum’s risk-mitigation initiatives and operational adjustments will drive long-term outperformance, or if challenges in core business segments will continue to weigh on results.
Ad
Unum Stock: Buy or Sell?! New Unum Analysis from September 5 delivers the answer:
The latest Unum figures speak for themselves: Urgent action needed for Unum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 5.
Unum: Buy or sell? Read more here...